hydrazine and inp 0341
hydrazine has been researched along with inp 0341 in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Henriques-Normark, B; Muschiol, S; Normark, S; Subtil, A | 1 |
| Chu, H; de la Maza, LM; Elofsson, M; Keyser, P; Peterson, EM; Slepenkin, A | 1 |
| Chu, H; Elofsson, M; Keyser, P; Peterson, EM; Slepenkin, A | 1 |
| Bastidas, RJ; Bergström, S; Elofsson, M; Engström, P; Fields, KA; Gylfe, A; Nguyen, BD; Nilsson, I; Normark, J; Valdivia, RH; Wolf-Watz, H | 1 |
| Andersson, SB; Bergström, CA; Fagerberg, JH; Pedersen, C; Peterson, EM; Slepenkin, A | 1 |
| Anantharajah, A; Buyck, JM; Mingeot-Leclercq, MP; Sundin, C; Tulkens, PM; Van Bambeke, F | 1 |
| Elofsson, M; Hägglund, U; Rhöös, E; Scherman Norberg, H; Sundin, C; Uusitalo, P | 1 |
| Elofsson, M; Roy, S; Sharma, P | 1 |
Other Studies
8 other study(ies) available for hydrazine and inp 0341
| Article | Year |
|---|---|
Small molecule inhibitors of the Yersinia type III secretion system impair the development of Chlamydia after entry into host cells.
Topics: Actins; Anti-Bacterial Agents; Chlamydia; Chlamydia Infections; Dose-Response Relationship, Drug; Gene Expression Regulation, Bacterial; GTP Phosphohydrolases; HeLa Cells; Humans; Hydrazines; Yersinia | 2009 |
Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae.
Topics: Administration, Intravaginal; Animals; Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Disease Models, Animal; Female; Gonorrhea; HeLa Cells; Humans; Hydrazines; Lactobacillus; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Vagina | 2010 |
Protection of mice from a Chlamydia trachomatis vaginal infection using a Salicylidene acylhydrazide, a potential microbicide.
Topics: Administration, Intravaginal; Animals; Anti-Infective Agents; Bacterial Load; Chlamydia Infections; Chlamydia trachomatis; Female; Hydrazines; Mice; Mice, Inbred C3H; Vagina | 2011 |
Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (HemG) and Chlamydia trachomatis infectivity.
Topics: Amino Acid Sequence; Bacterial Proteins; Catalytic Domain; Chlamydia trachomatis; Drug Resistance, Bacterial; HeLa Cells; Heme; Humans; Hydrazines; Iron; Models, Molecular; Molecular Sequence Data; Mutation; Protoporphyrinogen Oxidase | 2013 |
Formulation of the microbicide INP0341 for in vivo protection against a vaginal challenge by Chlamydia trachomatis.
Topics: Animals; Anti-Infective Agents; Chlamydia trachomatis; Delayed-Action Preparations; Disease Models, Animal; Female; HeLa Cells; Humans; Hydrazines; Lymphogranuloma Venereum; Mice; Vagina; Vaginal Creams, Foams, and Jellies | 2014 |
Salicylidene Acylhydrazides and Hydroxyquinolines Act as Inhibitors of Type Three Secretion Systems in Pseudomonas aeruginosa by Distinct Mechanisms.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Line; Humans; Hydrazines; Hydroxyquinolines; Inflammasomes; Pseudomonas aeruginosa; Type III Secretion Systems; Virulence | 2017 |
The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo.
Topics: Administration, Cutaneous; ADP Ribose Transferases; Animals; Anti-Bacterial Agents; Bacterial Physiological Phenomena; Bacterial Proteins; Bacterial Toxins; Biofilms; Burns; Drug Resistance, Multiple, Bacterial; Flagella; HeLa Cells; Humans; Hydrazines; Male; Mice, Inbred BALB C; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Sigma Factor; Survival Analysis; Trans-Activators; Virulence; Wound Infection | 2017 |
Attenuation of
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cell Line; Cornea; Disease Models, Animal; Epithelial Cells; Humans; Hydrazines; Keratitis; Mice; Mice, Inbred C57BL; Pseudomonas aeruginosa; Pseudomonas Infections; Type III Secretion Systems; Virulence | 2020 |